Clinical Trial Update: Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

This update summarizes a Phase 2 clinical trial evaluating epratuzumab as treatment for Non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Epratuzumab (epratuzumab)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lymphoma | Phase 2 | Status: UNKNOWN